Rare Voices Podcast

Some people are the unique combination of visionary genius and thoughtful character. They connect the head and the heart. Our guest for Rare Voices Episode 3 is one such person, Ken Greathouse. Ken is a veteran commercialization guru and a great friend. Ken has a decades-long point-of-view on developing innovative therapies with a proven track record in commercialization, sales and marketing for pharmaceuticals. When Ken sold Manchester Pharmaceuticals, he created the Greathouse Family Foundation with his wife, three sons, and daughter-in-law, in an effort to fund research for patients with orphan and rare disorders. The phrase, “That’s the way we have always done it,” does not apply to Ken. If you are ready to be provoked into a new way of thinking about how we could bring new therapies to market for people who need them the most, you won’t be disappointed with this conversation in Episode 3.

Show Notes

Some people are the unique combination of visionary genius and thoughtful character. They connect the head and the heart. Our guest for Rare Voices Episode 3 is one such person, Ken Greathouse. Ken is a veteran commercialization guru and a great friend. Ken has a decades-long point-of-view on developing innovative therapies with a proven track record in commercialization, sales and marketing for pharmaceuticals. When Ken sold Manchester Pharmaceuticals, he created the Greathouse Family Foundation with his wife, three sons, and daughter-in-law, in an effort to fund research for patients with orphan and rare disorders. The phrase, “That’s the way we have always done it,” does not apply to Ken. If you are ready to be provoked into a new way of thinking about how we could bring new therapies to market for people who need them the most, you won’t be disappointed with this conversation in Episode 3.

What is Rare Voices Podcast?

Rare Voices reveals the wisest path to a fulfilled life for patients with rare and orphan disorders. Brought to you by the people at Optime Care, a pioneering specialty pharmacy. In each episode, we uncover insights from patient advocates, pharmaceutical innovators, leaders in insurance, physicians, and caregivers. Prepare to provoke your mind and fuel your drive to serve rare and orphan patient populations.